VIS-267

N/A

Report date: 2023/04/14 14:58:55

Base Information

Drug NameVIS-267
Drug Alias NameVIS-267VIS267
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-C3 Convertase
TargetsComplement C3 Convertase
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVisterra Inc
China Registration ClassN/A

Develop Information

Active CompaniesVisterra Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A